🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Michael Choi

University of California, Irvine

ORCID: 0000-0003-3525-9613
Business, Management and AccountingEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

3in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 4 papers. Top paper: Venetoclax for patients with chronic lymphocytic leukemia who progressed during or after idelalisib therapy.

132 citations

Michael Choi, Richard R. Furman, Herbert Eradat, Leonard Heffner, Jeffrey A. Jones +10 more

4 citations

Jesse Chan, Michael Choi, Karanbir Singh, Giles W. Slocum, Rose Calixte +3 more

1 citations

Marin Bont, Shruti Warhadpande, Michael Choi, Jose Cedano, Heather Greenwood +20 more

49 citations

Colin S. McCoin, Alex Von Schulze, Claire J. Houchen, Michael Choi, John P. Thyfault +1 more